Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 8529542, 11 pages
https://doi.org/10.1155/2017/8529542
Research Article

Human β-Defensin 3 Reduces TNF-α-Induced Inflammation and Monocyte Adhesion in Human Umbilical Vein Endothelial Cells

1Department of Periodontology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China
2Central Laboratory of Stomatology, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China
3Department of Endodontics, Nanjing Stomatological Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China

Correspondence should be addressed to Fuhua Yan; moc.621@5002nayhf

Received 27 November 2016; Revised 27 January 2017; Accepted 14 February 2017; Published 28 February 2017

Academic Editor: Ulrich Eisel

Copyright © 2017 Tianying Bian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. B. Rice, L. L. Stoll, W. G. Li et al., “Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 23, no. 9, pp. 1576–1582, 2003. View at Google Scholar
  2. D. P. Ramji and T. S. Davies, “Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets,” Cytokine and Growth Factor Reviews, vol. 26, no. 6, pp. 673–685, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Landmesser, B. Hornig, and H. Drexler, “Endothelial function: a critical determinant in atherosclerosis?” Circulation, vol. 109, no. 21, supplement 1, pp. II27–II33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. S. Pober and W. C. Sessa, “Evolving functions of endothelial cells in inflammation,” Nature Reviews Immunology, vol. 7, no. 10, pp. 803–815, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Lai, C. Chung, B. Chen et al., “Gold nanoparticles compromise TNF-α-induced endothelial cell adhesion molecule expression through NF-κB and protein degradation pathways and reduce neointima formation in a rat carotid balloon injury model,” Journal of Biomedical Nanotechnology, vol. 12, no. 12, pp. 2185–2201, 2016. View at Publisher · View at Google Scholar
  6. T. Bian, L. Li, J. Lyu, D. Cui, L. Lei, and F. Yan, “Human β-defensin 3 suppresses Porphyromonas gingivalis lipopolysaccharide-induced inflammation in RAW 264.7 cells and aortas of ApoE-deficient mice,” Peptides, vol. 82, pp. 92–100, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Haddy, C. Sass, S. Droesch et al., “IL-6, TNF-α and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort,” Atherosclerosis, vol. 170, no. 2, pp. 277–283, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Chen and D. V. Goeddel, “TNF-R1 signaling: a beautiful pathway,” Science, vol. 296, no. 5573, pp. 1634–1635, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Wójciak-Stothard, A. Entwistle, R. Garg, and A. J. Ridley, “Regulation of TNF-α-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells,” Journal of Cellular Physiology, vol. 176, no. 1, pp. 150–165, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. G. McKenzie and A. J. Ridley, “Roles of Rho/ROCK and MLCK in TNF-α-induced changes in endothelial morphology and permeability,” Journal of Cellular Physiology, vol. 213, no. 1, pp. 221–228, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Haynes, J. E. McElveen, H. S. Dua, P. J. Tighe, and J. Liversidge, “Expression of human beta-defensins in intraocular tissues,” Investigative Ophthalmology and Visual Science, vol. 41, no. 10, pp. 3026–3031, 2000. View at Google Scholar · View at Scopus
  12. P. Bergman, L. Johansson, H. Wan et al., “Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection,” Infection and Immunity, vol. 74, no. 12, pp. 6982–6991, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. H. I. Kawsar, S. K. Ghosh, S. A. Hirsch, H. B. Koon, A. Weinberg, and G. Jin, “Expression of human β-defensin-2 in intratumoral vascular endothelium and in endothelial cells induced by transforming growth factor β,” Peptides, vol. 31, no. 2, pp. 195–201, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Baroni, G. Donnarumma, I. Paoletti et al., “Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells,” Peptides, vol. 30, no. 2, pp. 267–272, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Burgey, W. V. Kern, W. Römer, T. Sakinc, and S. Rieg, “The innate defense antimicrobial peptides hBD3 and RNase7 are induced in human umbilical vein endothelial cells by classical inflammatory cytokines but not Th17 cytokines,” Microbes and Infection, vol. 17, no. 5, pp. 353–359, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Li, T. Bian, J. Lyu, D. Cui, L. Lei, and F. Yan, “Human β-defensin-3 alleviates the progression of atherosclerosis accelerated by Porphyromonas gingivalis lipopolysaccharide,” International Immunopharmacology, vol. 38, pp. 204–213, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lyu, T. Bian, B. Chen et al., “β-defensin 3 modulates macrophage activation and orientation during acute inflammatory response to Porphyromonas gingivalis lipopolysaccharide,” Cytokine, vol. 92, pp. 48–54, 2017. View at Publisher · View at Google Scholar
  18. S. Kofler, T. Nickel, and M. Weis, “Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation,” Clinical Science, vol. 108, no. 3, pp. 205–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Gerhardt and K. Ley, “Monocyte trafficking across the vessel wall,” Cardiovascular Research, vol. 107, no. 3, pp. 321–330, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. F. K. Swirski, P. Libby, E. Aikawa et al., “Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata,” Journal of Clinical Investigation, vol. 117, no. 1, pp. 195–205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Cheng, S. J. McKeown, L. Santos et al., “Macrophage migration inhibitory factor increases leukocyte-endothelial interactions in human endothelial cells via promotion of expression of adhesion molecules,” Journal of Immunology, vol. 185, no. 2, pp. 1238–1247, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Jubeli, L. Moine, J. Vergnaud-Gauduchon, and G. Barratt, “E-selectin as a target for drug delivery and molecular imaging,” Journal of Controlled Release, vol. 158, no. 2, pp. 194–206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-K. Min, Y.-M. Kim, S. W. Kim et al., “TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-κB activation in endothelial cells,” Journal of Immunology, vol. 175, no. 1, pp. 531–540, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. B. Cines, E. S. Pollak, C. A. Buck et al., “Endothelial cells in physiology and in the pathophysiology of vascular disorders,” Blood, vol. 91, no. 10, pp. 3527–3561, 1998. View at Google Scholar · View at Scopus
  25. J. C. Mason, “Cytoprotective pathways in the vascular endothelium. Do they represent a viable therapeutic target?” Vascular Pharmacology, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-G. Lin, X.-Y. Yu, Y.-X. Chen et al., “De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits,” Circulation Research, vol. 87, no. 12, pp. 1202–1208, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Schmeisser, R. Marquetant, T. Illmer et al., “The expression of macrophage migration inhibitory factor 1α (MIF 1α) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability,” Atherosclerosis, vol. 178, no. 1, pp. 83–94, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Burger-Kentischer, H. Goebel, R. Seiler et al., “Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis,” Circulation, vol. 105, no. 13, pp. 1561–1566, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Kaneto, N. Katakami, M. Matsuhisa, and T.-A. Matsuoka, “Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis,” Mediators of Inflammation, vol. 2010, Article ID 453892, 11 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Taniyama and K. K. Griendling, “Reactive oxygen species in the vasculature: molecular and cellular mechanisms,” Hypertension, vol. 42, no. 6, pp. 1075–1081, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. C.-C. H. Li, M. Korner, D. K. Ferris, E. Chen, R.-M. Dai, and D. L. Longo, “NF-κB/Rel family members are physically associated phosphoproteins,” Biochemical Journal, vol. 303, no. 2, pp. 499–506, 1994. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Gloire, S. Legrand-Poels, and J. Piette, “NF-κB activation by reactive oxygen species: fifteen years later,” Biochemical Pharmacology, vol. 72, no. 11, pp. 1493–1505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Z. Zhou, M. C. Connell, and D. J. MacEwan, “TNFR1-induced NF-κB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells,” Cellular Signalling, vol. 19, no. 6, pp. 1238–1248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. W. V. Berghe, S. Plaisance, E. Boone et al., “p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κB p65 transactivation mediated by tumor necrosis factor,” Journal of Biological Chemistry, vol. 273, no. 6, pp. 3285–3290, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Nakano, A. Nakajima, S. Sakon-Komazawa, J.-H. Piao, X. Xue, and K. Okumura, “Reactive oxygen species mediate crosstalk between NF-κB and JNK,” Cell Death and Differentiation, vol. 13, no. 5, pp. 730–737, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Semple, H. Macpherson, S. Webb et al., “Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF,” European Journal of Immunology, vol. 41, no. 11, pp. 3291–3300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. U. K. Gursoy and E. Könönen, “Understanding the roles of gingival beta-defensins,” Journal of Oral Microbiology, vol. 4, no. 1, Article ID 15127, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. F. Semple, S. Webb, H. N. Li et al., “Human β-defensin 3 has immunosuppressive activity in vitro and in vivo,” European Journal of Immunology, vol. 40, no. 4, pp. 1073–1078, 2010. View at Publisher · View at Google Scholar
  39. N. Funderburg, M. M. Lederman, Z. Feng et al., “Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18631–18635, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. Q. Sheng, Z. Lv, W. Cai et al., “Human β-defensin-3 promotes intestinal epithelial cell migration and reduces the development of necrotizing enterocolitis in a neonatal rat model,” Pediatric Research, vol. 76, no. 3, pp. 269–279, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. H. G. Boman, “Peptide antibiotics and their role in innate immunity,” Annual Review of Immunology, vol. 13, pp. 61–92, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Jarczak, E. M. Kościuczuk, P. Lisowski et al., “Defensins: natural component of human innate immunity,” Human Immunology, vol. 74, no. 9, pp. 1069–1079, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Chen, Y. Yang, Z. Shi, M.-Q. Gao, and Y. Zhang, “Effects of genetically modified milk containing human beta-defensin-3 on gastrointestinal health of mice,” PLoS ONE, vol. 11, no. 7, Article ID e0159700, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Thery, J. C. Tharappel, J. Kraszewska, M. Beckett, U. Bond, and E. K. Arendt, “Antifungal activity of a synthetic human β-defensin 3 and potential applications in cereal-based products,” Innovative Food Science & Emerging Technologies, vol. 38, pp. 160–168, 2016. View at Publisher · View at Google Scholar
  45. S. Lim, K. Ahn, C. Kim et al., “Antifungal effects of synthetic human β-defensin 3-C15 peptide,” Restorative Dentistry & Endodontics, vol. 41, no. 2, p. 91, 2016. View at Publisher · View at Google Scholar
  46. J. Y. Lee, J. S. Suh, J. M. Kim et al., “Identification of a cell-penetrating peptide domain from human beta-defensin 3 and characterization of its anti-inflammatory activity,” International Journal of Nanomedicine, vol. 10, pp. 5423–5434, 2015. View at Publisher · View at Google Scholar · View at Scopus
  47. W. C. Aird, “Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms,” Circulation Research, vol. 100, no. 2, pp. 158–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. J. N. Topper and M. A. Gimbrone Jr., “Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype,” Molecular Medicine Today, vol. 5, no. 1, pp. 40–46, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. D. A. Chistiakov, A. N. Orekhov, and Y. V. Bobryshev, “Effects of shear stress on endothelial cells: go with the flow,” Acta Physiologica, vol. 219, no. 2, pp. 382–408, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Hamada, M. Osaka, and M. Yoshida, “Cell density impacts epigenetic regulation of cytokine-induced E-selectin gene expression in vascular endothelium,” PLoS ONE, vol. 9, no. 4, Article ID e90502, 2014. View at Publisher · View at Google Scholar · View at Scopus